The future of inhaled insulin and incretinmimetics in the management of diabetes.
Barnett
Anthony H
AH
Department of Diabetes/Endocrinology, University of Birmingham, United Kingdom. anthony.barnett@heartofengland.nhs.uk
D000280:Administration, Inhalation; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004867:Equipment Design / Q000191:economics; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*
D007004:Hypoglycemic Agents; D007328:Insulin